Argenta

What Argenta does

Argenta is a global contract research, development, and manufacturing organization (CRO/CDMO) dedicated exclusively to the animal health and nutrition industry. The company offers an integrated 'molecule to market' service model spanning pre-clinical studies, clinical development, regulatory affairs, product development, and commercial-scale manufacturing. Argenta operates four EMA and FDA GMP-approved manufacturing sites across three continents and produces over one billion doses of animal health pharmaceuticals annually across 125+ commercial products and 600+ SKUs. Its technology stack includes proprietary drug delivery platforms covering chew matrices, transdermal, dispersible granules, controlled-release microspheres, and controlled-release intraruminal capsules, alongside veterinary-specific electronic data capture (EDC) systems and AAALAC-accredited pre-clinical facilities across three locations with 45 ABSL-2 rooms.

The company generates revenue through project-based B2B contract services, targeting enterprise animal health companies (including the majority of the top 10 global animal health firms), food and feed companies, and adjacent nutrition segments spanning both companion animals and production animals. Distribution is direct enterprise sales with no third-party channel layer, and pricing is not publicly disclosed as engagements are tailored to client requirements. Argenta reports a 95% regulatory submission success rate across 500+ food and feed submissions and 50+ product registrations through FDA/CVM, EMA, and EFSA, and has been named S&P Global's Animal Health Award for Best Services Company five times in the past six years.

The corporate structure is anchored by Argenta Holdco Limited (UK-domiciled parent, ultimate holding company Argenta Topco Limited), with KKR as majority investor since November 2020 and additional capital from NovaQuest via a US$30 million product financing in May 2021. Since 2021, Argenta has executed a roll-up strategy, acquiring KLIFOVET (2021), Pen & Tec Consulting (2022), Ondax Scientific (2022), Midwest Veterinary Services (2023), and a Shawnee sterile fill-finish manufacturing site (2024). Leadership transitions in 2024-2025, including a new CEO (Matthew Stober, September 2025) and CFO (Alastair Hay, January 2024), have accompanied CRO platform realignment (January 2025) and US operations consolidation (December 2025).

Name

Argenta

Legal name

Argenta Holdco Limited

Website

https://argentaglobal.com

Company type

Private

Founded year

2006

Operating status

Operating

Headcount range

501–1,000 employees

Short description

Argenta is a global animal health and nutrition contract research, development, and manufacturing organization (CRO/CDMO) offering integrated molecule-to-market services across pre-clinical, clinical, regulatory, and commercial manufacturing for animal health, food, and feed companies.

Ownership category

akta.pro rank

Product category

Animal Health Contract Research, Development and Manufacturing Services

NAICS

Scientific Research and Development Services (5417)

SIC

Pharmaceutical Preparations (2834), Services-Engineering, Accounting, Research, Management (8700)

akta.pro primary industry

Clinical Trial Material (CTM) Manufacturing & Supply CDMO (HLAGABAK)

akta.pro secondary industries

Clinical CROs (Phase I–IV) (HLAGAAAA), Regulatory Strategy & Global Submissions (IND/CTA/NDA/BLA/MAA) (HLAGAKAA)

Keywords

• Animal health CRO
• Veterinary contract manufacturing
• Contract development services
• Animal pharmaceuticals CDMO
• Veterinary regulatory affairs

Headquarters

HQ city

Auckland

HQ country

New Zealand

HQ region

Oceania

Offices10 records

Markets served

GTM type

B2B

Offering type

Services

Cost components

Personnel, Operations, Infrastructure, Technology or R&D, Marketing or Sales

Revenue model

1. Contract Research Services (CRO): Full-service contract research including pre-clinical studies, clinical studies, regulatory affairs, data management, biostatistics, and animal/human nutrition services. Revenue generated through project-based fees for research services.
2. Contract Manufacturing Services (CMO): Manufacturing services including clinical trial supplies, full-scale registration batches, and commercial production. Producing and supplying 125+ different commercial products and 600+ different SKUs.
3. Contract Development Services (CDO): Product development services including biological development, pharmaceutical development, method development, and technology transfer.

Go-to-market motion1 record

Distribution channels1 record

Marketing channels7 records

Core offering

Argenta provides integrated contract research (CRO), contract development (CDO), and contract manufacturing (CMO) services for the animal health industry. Its offering covers pre-clinical and clinical studies, regulatory affairs, product development, and manufacturing of pharmaceutical and nutritional animal health products, supporting clients from molecule to market.

Product overview

Argenta is the world's only global animal health and nutrition contract research, development, and manufacturing organisation (CRO/CDMO), offering an integrated 'molecule to market' approach. The company provides three interconnected service pillars: Research Services (CRO) covering clinical studies, pre-clinical studies, regulatory affairs, animal and human nutrition, data management, and biostatistics; Manufacturing Services (CMO) including EMA/FDA GMP-approved facilities for commercial-scale production; and Product Development Services (CDO) encompassing biological, pharmaceutical, and method development. These core services are supported by proprietary drug delivery technology platforms (chew matrices, transdermal, dispersible granules, controlled-release microspheres, and intraruminal capsules), comprehensive regulatory services, and specialized solutions spanning opportunity assessment, proof of concept, early development, and clinical development. The company operates research sites in Germany, New Zealand, Spain, UK, and the US, with manufacturing facilities on three continents.

Differentiator

Problem solved

Functional benefit

Products and services

• Contract Research (CRO) Services
• Contract Manufacturing (CMO) Services
• Contract Development (CDO) Services
• Regulatory Affairs Services
• Data Management and Biostatistics Services
• Animal and Human Nutrition Regulatory Services
• Pre-Clinical Studies
• Clinical Development Services

Quantifiable outcome

• 50+ product registrations through FDA/CVM, EMA, and EFSA
• +5 more outcomes

Named customers1 record

Segments4 records

Ideal customer profiles2 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature4 records

Partnerships

Three partnerships are on record, tiered core and minor.

• IPIFF (International Platform of Insects for Food and Feed)coreStrategic or Co-development Partner · 23 March 2026Strategic collaboration to accelerate innovation in insect-based animal health and nutrition products and human nutrition products. IPIFF represents the insect production sector at EU level.
• Pentec ConsultingminorStrategic or Co-development PartnerFood and feed regulatory consulting partnership referenced in services - Argenta recommends Pentec Consulting for specialized services.
• Midwest Veterinary Services (MVS)coreStrategic or Co-development PartnerAcquired MVS to strengthen clinical research capabilities. MVS operates as part of Argenta's US CRO operations.

Scale indicators12 records

Recent moves9 records

Expansion highlights6 records

Emerging players

• Ceva Santé Animale: Fast-growing global animal health pharmaceutical company with internal CDMO-style capabilities. Comparable in vertical focus and customer overlap, though Ceva is primarily a product company expanding into biologics manufacturing.

Broad incumbents

• Elanco Animal Health: Global animal health company with internal manufacturing and R&D. Both customer of Argenta and operator of parallel CDMO-style capabilities; co-invested with Argenta in Stonehaven Incubate.
• Zoetis: World's largest animal health company with significant in-house manufacturing, R&D, and regulatory functions. Represents the largest class of Argenta's enterprise customers and the strategic benchmark for animal health services scale.
• Charles River Laboratories: Global CRO/CDMO serving both human and animal health research and manufacturing. Overlaps with Argenta on preclinical animal studies and contract manufacturing, though Charles River operates at much larger scale across the broader life sciences market.
• Labcorp (formerly Covance): Global CRO with animal health preclinical and clinical capabilities as part of a broader life sciences portfolio. Comparable to Argenta in clinical study design and data management but at much larger, diversified scale.
• Boehringer Ingelheim Animal Health: Major animal health pharmaceutical company with substantial in-house manufacturing and R&D. Significant customer overlap with Argenta and a comparable animal-health-only strategic orientation.

Others

• IDEXX Laboratories: Veterinary diagnostics and reference laboratory leader. Adjacent rather than directly competitive; shares the animal health end-market and overlapping customer base of veterinary practices.
• Phibro Animal Health: Animal health and nutrition company with internal development and manufacturing capabilities. Overlaps with Argenta in animal nutrition regulatory and CMC, though Phibro is primarily a product company rather than a service provider.

Direct peers

• Eurofins Scientific: Testing and contract services group with animal health and food/feed regulatory testing capabilities. Comparable to Argenta in regulatory affairs, food/feed submissions, and bioanalytical services supporting animal health customers.
• Triveritas: Veterinary regulatory consultancy and CRO focused on animal health product development. Directly comparable to Argenta's Klifovet-originated European regulatory and clinical offering for veterinary medicinal products.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat6 records

Key risks6 records

Key highlights7 records

Customer concentration

• LinkedInlinkedin.com/company/argentaglobal

Revenue estimate

Valuation estimate

Number of profiles

Profiles18 records

Subsidiaries14 records

Funding overview

Funding rounds1 record

Investors2 records

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A1 record

Investments1 record

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Argenta